Results 201 to 210 of about 107,687,715 (215)

High Syndecan-1 Expression in Breast Carcinoma Is Related to an Aggressive Phenotype and to Poorer Prognosis

Cancer, 2003
Orazio Caffo, Claudio Doglioni, Silvio Marco Veronese   +2 more
exaly  

Heparanase-Enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression

Journal of Histochemistry and Cytochemistry, 2020
Israel Vlodavsky, Jillian R Richter, Robert P Richter   +2 more
exaly  

Syndecan-2 Induces Filopodia and Dendritic Spine Formation via the Neurofibromin–PKA–Ena/VASP Pathway

Journal of Cell Biology, 2007
Yi-Ping Hsueh, Yi-Ling Lin
exaly  

Syndecan-1 and Syndecan-4 Are Overexpressed in an Estrogen Receptor-Negative, Highly Proliferative Breast Carcinoma Subtype

Breast Cancer Research and Treatment, 2006
Andreas Friedl, Jens Eickhoff, Fusun Baba   +2 more
exaly  

Syndecan-2 Can Promote Clearance of T-Cell Receptor/CD3 From the Cell Surface

Immunology, 2012
Xavier Rovira-Clavé, Manuel Reina, Enric Espel   +2 more
exaly  

Syndecan-1 Expression Has Prognostic Significance in Head and Neck Carcinoma

British Journal of Cancer, 1999
Heikki Joensuu, P Heikkilä, Markku Jalkanen   +2 more
exaly  

Serum Syndecan-4 as a Possible Biomarker in Patients With Acute Pneumonia.

Journal of Infectious Diseases, 2015
Kohsuke Tsuchiya, Charles W Frevert, Tetsuhito Kojima   +2 more
exaly  

Prognostic Impact of Syndecan-1 Expression in Invasive Ductal Breast Carcinomas

British Journal of Cancer, 2008
Jean-Sébastien Frénel, Loic Campion, F Dravet   +2 more
exaly  

Syndecan-4 Enhances Therapeutic Angiogenesis After Hind Limb Ischemia in Mice With Type 2 Diabetes

Advanced Healthcare Materials, 2016
Marjan Majid, Michael B Sherman, Subhamoy Das   +2 more
exaly  

Prognostic Value of Syndecan-1 Expression in Breast Cancer

Oncology, 2004
Stig Nordling, Johan Lundin, Caj Haglund
exaly